These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27384062)

  • 21. ACOG Committee Opinion No. 401: Relationships with industry.
    American College of Obstetricians and Gynecologists Committee on Ethics
    Obstet Gynecol; 2008 Mar; 111(3):799-804. PubMed ID: 18310391
    [No Abstract]   [Full Text] [Related]  

  • 22. Ethics and Disclosure.
    Pinzur MS
    Foot Ankle Int; 2019 Mar; 40(3):364. PubMed ID: 30700164
    [No Abstract]   [Full Text] [Related]  

  • 23. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine.
    Rubin EB; Bernat JL
    Headache; 2008; 48(10):1545-9. PubMed ID: 19076654
    [No Abstract]   [Full Text] [Related]  

  • 24. Disclosing drug companies payments should be compulsory, say top earners.
    Jarvies D
    BMJ; 2016 Jul; 354():i3716. PubMed ID: 27377065
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial policies on financial disclosure.
    Jacobson MF; Sharpe VA; Angell M; Ashford NA; Blum A; Chary LK; Cho M; Coull BC; Davis D; Doolittle RF; Egilman D; Epstein SS; Greenberg M; Hooper K; Huff J; Joshi TK; Krimsky S; LaDou J; Levenstein C; Miles S; Needleman H; Pellegrino ED; Ravanesi B; Sass J; Schecter A; Schneiderman JS; Schubert D; Soffritti M; Suzuki D; Takaro TK; Temple NJ; Terracini B; Thompson A; Wallinga D; Wing S
    Nat Neurosci; 2003 Oct; 6(10):1001. PubMed ID: 14513030
    [No Abstract]   [Full Text] [Related]  

  • 26. Financial disclosure for review authors.
    Nat Neurosci; 2003 Oct; 6(10):997. PubMed ID: 14513027
    [No Abstract]   [Full Text] [Related]  

  • 27. Doctors and drug companies--scrutinizing influential relationships.
    Campbell EG
    N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial policies on financial disclosure.
    Carroll BJ; Rubin RT
    Nat Neurosci; 2003 Oct; 6(10):999-1000; author reply 1000-1. PubMed ID: 14513028
    [No Abstract]   [Full Text] [Related]  

  • 29. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 30. Unreported financial disclosures.
    Rosenberg RN
    Arch Neurol; 2008 Jul; 65(7):992. PubMed ID: 18625879
    [No Abstract]   [Full Text] [Related]  

  • 31. Professional Medical Associations and Divestiture from Industry: An Ethical Imperative for Pain Society Leadership.
    Rothman DJ
    Pain Med; 2016 Feb; 17(2):218-9. PubMed ID: 26814303
    [No Abstract]   [Full Text] [Related]  

  • 32. An MS patient loses trust when she finds out her doctor is paid by drug companies.
    Wolston M
    Health Aff (Millwood); 2011 Dec; 30(12):2449-52. PubMed ID: 22147873
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disclosure of conflicts of interest in the Tijdschrift voor Psychiatrie].
    Bergoets M; Pieters G
    Tijdschr Psychiatr; 2009; 51(12):893-7. PubMed ID: 20047169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted therapies: Manufacturer sponsorship bias in economic analyses matters.
    Kerr D; Elzawawy A
    Nat Rev Clin Oncol; 2012 May; 9(6):309-10. PubMed ID: 22547216
    [No Abstract]   [Full Text] [Related]  

  • 35. The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment.
    Hwong AR; Sah S; Lehmann LS
    J Gen Intern Med; 2017 Nov; 32(11):1186-1192. PubMed ID: 28717899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letting the sunshine in on doctor-pharma relationships.
    Jack A
    BMJ; 2011 Oct; 343():d6459. PubMed ID: 21990283
    [No Abstract]   [Full Text] [Related]  

  • 37. Pain Medicine Ethics Forum: Key Opinion Leaders with Industry Conflicts of Interest Should Be Able to Hold Leadership Positions in Professional Medical Associations.
    Wallace MS
    Pain Med; 2016 Feb; 17(2):218. PubMed ID: 26814302
    [No Abstract]   [Full Text] [Related]  

  • 38. Act II of the Sunshine Act.
    Pham-Kanter G
    PLoS Med; 2014 Nov; 11(11):e1001754. PubMed ID: 25369363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letting the sunshine in: shining a new light on physician-industry relationships.
    Bruguera CM; Hirsch JA
    J Neurointerv Surg; 2010 Mar; 2(1):80-2. PubMed ID: 21990565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. US to require public disclosure of drug and device industry's financial ties to doctors.
    Epstein K
    BMJ; 2012 Jan; 344():e515. PubMed ID: 22262802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.